journal article·2021-02-02

Dendronized Gold Nanoparticles as Carriers for gp160 (HIV-1) Peptides: Biophysical Insight into Complex Formation

Zuzana Garaiova, Sopio Melikishvili, Sylwia Michlewska, Maksim Ionov, Elzbieta Pedziwiatr-Werbicka, Iveta Waczulikova, Tibor Hianik, Rafael Gomez-Ramirez, Francisco Javier de la Mata, Maria Bryszewska

Langmuir· Volume 37· Issue 4
Publisher page

Abstract

The unavailability of effective and safe human immunodeficiency virus (HIV) vaccines incites several approaches for development of the efficient antigen/adjuvant vaccination composite. In this study, three different dendronized gold nanoparticles (AuNPs 13-15) were investigated for a complexation ability with gp160 synthetic peptides derived from an HIV envelope. It has been shown that HIV peptides interacted with nanoparticles as evident from the changes in their secondary structures, restricted the mobility of the attached fluorescence dye, and enhanced peptide helicity confirmed by the fluorescence polarization and circular dichroism results. Transmission electron microscopy visualized complexes as cloud-like structures with attached nanoparticles. AuNP 13-15 nanoparticles bind negatively charged peptides depending on the number of functional groups; the fastest saturation and peptide retardation were observed for the most dendronized nanoparticle as indicated from dynamic light scattering, laser Doppler velocimetry, and agarose gel electrophoresis experiments. Dendronized gold nanoparticles can be considered one of the potential HIV peptide-based vaccination platforms.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: HIV Research and Treatment · Immunotherapy and Immune Responses · vaccines and immunoinformatics approaches

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Nuclear Physics and Biophysics, Faculty of Mathematics, Physics and Informatics, Comenius University, Bratislava 842 48, Slovakia

Laboratory of Microscopic Imaging and Specialized Biological Techniques, Faculty of Biology and Environmental Protection, University of Lodz, Lodz 90-237, Poland

Department of General Biophysics, Faculty of Biology and Environmental Protection, University of Lodz, Lodz 90-237, Poland

Inorganic Chemistry Department, IQAR, University Alcala, Alcala de Henares 28801, Spain

Ramón y Cajal Health Research Institute (IRYCIS), IRYCIS, Madrid 28034, Spain

Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid 28029, Spain

Funding

Narodowa Agencja Wymiany Akademickiej · Comunidad de Madrid · Vedeck? Grantov? Agent?ra M?VVa? SR a SAV · Centro de Investigaci?n Biom?dica en Red en Bioingenier?a, Biomateriales y Nanomedicina · European Regional Development Fund · Ministerio de Econom?a y Competitividad · European Cooperation in Science and Technology · Instituto de Salud Carlos III · Junta de Comunidades de Castilla-La Mancha · Agent?ra na Podporu V?skumu a V?voja

References (41)

Show source-provided references
1. World Health Organization (July 6th 2020) Key facts HIV/AIDS, https://www.who.int/news-room/fact-sheets/detail/hiv-aids.
2. 10.1097/QAD.0b013e328353f3f110.1097/QAD.0b013e328353f3f1 ↗
3. HIV Vaccine Trials Network (February 3rd 2020) Fact sheet: Understanding why vaccinations in the HVTN 702 Uhambo study were stopped, http://www.hvtn.org/content/dam/hvtn/MEDIAROOM/Fact%20Sheet%20-%20Understanding%20the%20702%20Outcome.pdf.
4. 10.1016/j.provac.2013.06.01010.1016/j.provac.2013.06.010 ↗
5. 10.1016/j.vaccine.2013.11.06910.1016/j.vaccine.2013.11.069 ↗
6. 10.1038/s41565-020-0739-910.1038/s41565-020-0739-9 ↗
7. 10.3390/molecules2205085710.3390/molecules22050857 ↗
8. 10.1080/14760584.2020.175807010.1080/14760584.2020.1758070 ↗
9. 10.1186/1556-276X-8-7210.1186/1556-276X-8-72 ↗
10. 10.1586/14760584.2016.114105410.1586/14760584.2016.1141054 ↗
11. 10.1007/978-1-4614-4433-6_1010.1007/978-1-4614-4433-6_10 ↗
12. 10.4161/hv.2587610.4161/hv.25876 ↗
13. 10.1021/acs.bioconjchem.5b0007710.1021/acs.bioconjchem.5b00077 ↗
14. 10.1039/C5SC03892H10.1039/C5SC03892H ↗
15. 10.1371/journal.pbio.300032810.1371/journal.pbio.3000328 ↗
16. 10.2217/nnm.14.17210.2217/nnm.14.172 ↗
17. Starpharma, (April 15th 2020) SPL7013 shows significant activity against SARS-CoV-2 (coronavirus), https://starpharma.com/news/story/spl7013-shows-significant-activity-against-sars-cov-2-coronavirus.
18. 10.1016/j.nano.2013.03.00410.1016/j.nano.2013.03.004 ↗
19. 10.2147/IJN.S9635210.2147/IJN.S96352 ↗
20. 10.1186/s12951-019-0500-410.1186/s12951-019-0500-4 ↗
21. 10.1039/C6DT03791G10.1039/C6DT03791G ↗
22. 10.1016/j.ijbiomac.2017.11.00410.1016/j.ijbiomac.2017.11.004 ↗
23. Lakowicz J. R. · 2007
24. 10.1002/cyto.99008010610.1002/cyto.990080106 ↗
25. 10.1038/nprot.2006.20210.1038/nprot.2006.202 ↗
26. Malkov, S. N.; Zivkovic, M. V.; Beljanski, M. V.; Zaric, S. D. Correlations of amino acids with secondary structrure types: connections with amino acid structure. 2005, arXiv:qbio/0505046 (q-bio.BM).
27. 10.1021/ja047719h10.1021/ja047719h ↗
28. 10.1002/anie.20060096510.1002/anie.200600965 ↗
29. 10.2174/0929867311320999019210.2174/09298673113209990192 ↗
30. Malvern Instruments Worldwide. Dynamic Light Scattering Common terms defined. Inform White paper 2011, http://www.biophysics.bioc.cam.ac.uk/wp-content/uploads/2011/02/DLS_Terms_defined_Malvern.pdf.
31. 10.3390/pharmaceutics1002005710.3390/pharmaceutics10020057 ↗
32. 10.1134/S1061933X1101007810.1134/S1061933X11010078 ↗
33. 10.1016/j.jconrel.2016.06.01710.1016/j.jconrel.2016.06.017 ↗
34. 10.1016/j.colsurfb.2016.09.02110.1016/j.colsurfb.2016.09.021 ↗
35. 10.3390/cells810120910.3390/cells8101209 ↗
36. 10.1155/2007/2679610.1155/2007/26796 ↗
37. 10.1021/jp035644i10.1021/jp035644i ↗
38. 10.1166/jbn.2012.136910.1166/jbn.2012.1369 ↗
39. 10.1016/j.ijpharm.2015.03.03410.1016/j.ijpharm.2015.03.034 ↗
40. 10.1016/j.colsurfb.2012.07.01110.1016/j.colsurfb.2012.07.011 ↗
41. 10.1016/B978-0-12-416020-0.00007-310.1016/B978-0-12-416020-0.00007-3 ↗